The 100 billion Chinese medicine formula granule market, entrants are increasing their layout

[Pharmaceutical Network Market Analysis] Recently, Jilin Aodong announced that its holding subsidiary Jilin Aodong Yanbian Pharmaceutical Co.
, Ltd.
("Yanbian Pharmaceutical") has recently received 25 "Chinese Medicine Formula Granules Listing Recording Certificates"
.

It is worth noting that as of the date of the announcement, a total of 162 "Traditional Chinese Medicine Formula Granules Listing Recording Certificates" have been obtained
.

The industry believes that with the listing and filing of a large number of traditional Chinese medicine granules, it is of great significance to expand the business of traditional Chinese medicine granules, which will create favorable conditions for the company's sustainable development and further enhance the company's core competitiveness
.

It is understood that the traditional Chinese medicine formula granules are made from traditional Chinese medicine decoction pieces as raw materials, through extraction, separation, concentration, drying, granulation, packaging and other production processes.

.

In recent years, the market of traditional Chinese medicine formula granules has achieved rapid development
.

According to data, from 2017 to 2020, the market size of China's traditional Chinese medicine formula granules increased from 19.
16 billion yuan to 29.
14 billion yuan, with a compound annual growth rate of about 15%
.

It is estimated in the industry that the market size of the domestic Chinese herbal decoction pieces may reach 344.
15 billion yuan in 2022, and the revenue of Chinese herbal formula granules is expected to reach 20-30% of the Chinese herbal medicine decoction pieces, about 68.
83-103.
245 billion yuan, an increase of 3-4 times compared with 2020.
space
.

 　　With the continuous expansion of the market, the number of companies accelerating the deployment of the traditional Chinese medicine formula granule market like Yanbian Pharmaceutical is actually increasing, and the methods are becoming more and more diverse
.

 　　For example, Kangyuan Pharmaceutical once stated that by 2021, the company has carried out research on the production process and quality standards of nearly 400 varieties of traditional Chinese medicine formula granules, and has formed stable process and quality standards and completed production verification
.

At the same time, the company has coordinated and arranged production lines, business personnel, etc.
, and is actively promoting the filing work in accordance with the regulatory policy of the Jiangsu Provincial Drug Administration on traditional Chinese medicine granules
.

 　　In terms of traditional Chinese medicine formula granule business, CR Sanjiu is increasing the number of products by strengthening the construction of medicinal material planting bases and research on medicinal material provenance, and relying on intelligent traditional Chinese medicine pharmacies to promote business, and promote the rapid realization of business with the improvement of the overall capacity of the industrial chain.
growth
.

 　　It is worth mentioning that while more and more traditional Chinese medicine companies are participating in the research and development and production of traditional Chinese medicine formula granules, which has greatly promoted the development of the industry, the performance of some traditional Chinese medicine companies has also begun to show a trend of rapid growth.

.

According to the online annual report of Hongri Pharmaceutical, in 2021, the business revenue of traditional Chinese medicine formula granules and decoction pieces has reached 4.
235 billion yuan, a year-on-year increase of 41.
60%
.

 　　According to the 2021 annual report of China Resources, its operating income in 2021 will increase by 2.
76% year-on-year to 5.
35 billion yuan
.

Among them, the specialty and traditional Chinese medicine formula granule business has achieved rapid growth.
It is estimated that China Resources Sanjiu traditional Chinese medicine formula granule business may exceed 3 billion yuan
.

 　　In addition, the annual report of Shenwei Pharmaceutical also shows that the business of traditional Chinese medicine formula granules has increased significantly
.

In 2021, the sales revenue of Shenwei Pharmaceutical's traditional Chinese medicine formula granules business will be 693 million yuan, an increase of 24.
5% over the same period of the previous year
.

 　　The industry believes that favorable policies are the main driving force for the development of the traditional Chinese medicine formula granule industry
.

In particular, the end of the pilot production and the release of restrictions on sales channels have accelerated the continuous expansion of the traditional Chinese medicine formula granule market
.

The industry predicts that under the guidance and support of the country's long-term policies, the domestic market of traditional Chinese medicine granules will continue to expand, and the industry will gradually become standardized
.

 　　Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.